PALM SPRINGS, Calif., Jan. 29 - The hey day of biotech funding may have passed. But 2002 will see some big mergers, the return of the IPO, and a tighter VC environment, according to Mary Tanner, senior managing director for the pharmaceutical and biotech industries at Bear, Stearns & Co.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.